AstraZeneca says reports COVID-19 vaccine efficacy is low in elderly are incorrect

Reuters | Frankfurt | Updated: 26-01-2021 03:26 IST | Created: 26-01-2021 03:15 IST
AstraZeneca says reports COVID-19 vaccine efficacy is low in elderly are incorrect
Representative Image Image Credit: ANI

AstraZeneca on Monday described German media reports saying its COVID-19 vaccine was shown to have a very low efficacy in the elderly as "completely incorrect".

German daily papers Handelsblatt and Bild said in separate reports on Monday the vaccine - co-developed by AstraZeneca and Oxford University - had an efficacy of 8% or less than 10%, respectively, in those over 65 and the German government did not expect the European regulator to approve the product for that age group.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)



Addressing conflict-related sexual violence at long last

... ...

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...


Latest News

Debate to begin in U.S. Senate on Biden's $1.9 trillion COVID-19 relief bill

A sharply divided U.S. Senate will begin a contentious debate on Friday on a 1.9 trillion coronavirus aid bill that is President Joe Bidens first major legislative initiative, with Democrats pressing ahead without any Republican support.The...




RS RS...

Alaska's Iditarod sled dog race is on, with COVID-19-altered course

The word Iditarod derives from an indigenous Alaskan name for a far distant place. Due to precautions made necessary by the COVID-19 pandemic, this years Iditarod Trail Sled Dog Race, which starts on Sunday, will be an especially distanced ...

Give Feedback